Advances in PET/CT Imaging for Breast Cancer

被引：8
作者：
de Jong, Dorine [1 ]
Desperito, Elise [2 ]
Al Feghali, Karine A. [3 ]
Dercle, Laurent [2 ]
Seban, Romain-David [4 ,5 ]
Das, Jeeban P. [6 ]
Ma, Hong [2 ]
Sajan, Abin [2 ]
Braumuller, Brian [2 ]
Prendergast, Conor [2 ]
Liou, Connie [2 ]
Deng, Aileen [7 ]
Roa, Tina [2 ]
Yeh, Randy [6 ]
Girard, Antoine [8 ]
Salvatore, Mary M. [2 ]
Capaccione, Kathleen M. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA
[2] Columbia Univ, Dept Radiol, Irving Med Ctr, New York, NY 10032 USA
[3] RefleXion Med Inc, Hayward, CA 94545 USA
[4] Inst Curie, Dept Nucl Med & Endocrine Oncol, F-92210 St Cloud, France
[5] Paris Sci & Lettres PSL Res Univ, Inst Curie, Lab Translat Imaging Oncol, F-91401 Orsay, France
[6] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[7] Novant Hlth, Dept Hematol & Oncol, 170 Med Pk Rd, Mooresville, NC 28117 USA
[8] Univ Rennes 1, Ctr Eugene Marquis, Dept Nucl Med, F-35000 Rennes, France
来源：
JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 13期
关键词：
breast cancer; triple negative breast cancer (TNBC); F-18-FDG; PET radiotracers; GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITORS; FIBROBLAST ACTIVATION PROTEIN; TISSUE FACTOR EXPRESSION; ANTIBODY-DRUG CONJUGATE; DIFFERENTIAL EXPRESSION; DOUBLE-BLIND; FACTOR-VIIA; IMMUNO-PET; MONOCLONAL-ANTIBODY;
D O I：
10.3390/jcm12134537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of F-18-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient's specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.
引用
收藏
页数：24
相关论文
共 214 条
  • [1] acrabstracts, About us
  • [2] Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
    Aerts, Hugo J. W. L.
    Dubois, Ludwig
    Perk, Lars
    Vermaelen, Peter
    van Dongen, Guus A. M. S.
    Wouters, Bradly G.
    Lambin, Philippe
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) : 123 - 131
  • [3] Fast Fluorine-18 labeling and preclinical evaluation of novel Mucin1 and its Folate hybrid peptide conjugate for targeting breast carcinoma
    Al Jammaz, I
    Al-Otaibi, B.
    Al-Malki, Y.
    Abousekhrah, A.
    Okarvi, S. M.
    [J]. EJNMMI RADIOPHARMACY AND CHEMISTRY, 2021, 6 (01)
  • [4] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    [J]. CANCER, 2009, 115 (21) : 5038 - 5047
  • [5] Role of ErbB Receptors in Cancer Cell Migration and Invasion
    Appert-Collin, Aline
    Hubert, Pierre
    Cremel, Gerard
    Bennasroune, Amar
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [6] The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques
    Aukema, T. S.
    Rutgers, E. J. Th.
    Vogel, W. V.
    Teertstra, H. J.
    Oldenburg, H. S.
    Peeters, M. T. F. D. Vrancken
    Wesseling, J.
    Russell, N. S.
    Olmos, R. A. Valdes
    [J]. EJSO, 2010, 36 (04): : 387 - 392
  • [7] 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
    Avril, Stefanie
    Muzic, Raymond F., Jr.
    Plecha, Donna
    Traughber, Bryan J.
    Vinayak, Shaveta
    Avril, Norbert
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 34S - 39S
  • [8] Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer
    Backhaus, Philipp
    Burg, Matthias C.
    Roll, Wolfgang
    Buether, Florian
    Breyholz, Hans-Joerg
    Weigel, Stefanie
    Heindel, Walter
    Pixberg, Michaela
    Barth, Peter
    Tio, Joke
    Schaefers, Michael
    [J]. RADIOLOGY, 2022, 302 (01) : 39 - 47
  • [9] Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer
    Bang, Ji-In
    Yoon, Hai-Jeon
    Kim, Born Sahn
    [J]. PLOS ONE, 2018, 13 (12):
  • [10] Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Mayer, I. A.
    Vahdat, L. T.
    Tolaney, S. M.
    Isakoff, S. J.
    Diamond, J. R.
    O'Shaughnessy, J.
    Moroose, R. L.
    Santin, A. D.
    Abramson, V. G.
    Shah, N. C.
    Rugo, H. S.
    Goldenberg, D. M.
    Sweidan, A. M.
    Iannone, R.
    Washkowitz, S.
    Sharkey, R. M.
    Wegener, W. A.
    Kalinsky, K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08) : 741 - 751
12345678910